PIPC Chairman Tony Coelho recently penned a letter to the Maryland Prescription Drug Affordability Board (PDAB) expressing concerns about the PDAB's methodology for setting the Upper Payment Limit (UPL) for selected drugs.
PIPC Urges Legislative Policy Committee to Reject Discriminatory Assessments in the Maryland PDAB2/5/2025
PIPC Chairman Tony Coelho recently submitted a letter to key members of the Maryland Legislative Policy Committee with concerns about legislation that would have serious implications for the patient and disability communities.
PIPC Chairman Tony Coelho submitted a letter to the Oregon Prescription Drug Affordability Board (PDAB) expressing concerns about the Board's use of value assessments that discriminate against patients and people with disabilities.
PIPC submitted a comment letter to the Washington Prescription Drug Affordability Board (PDAB) highlighting the concerns of patients and people with disabilities related to the PDAB’s potential use of discriminatory cost effectiveness analyses.
PIPC recently sent a letter to Senator Bill Ferguson and Delegate Adrianne Jones urging Maryland's Legislative Policy Committee to reject the Prescription Drug Affordability Board's (PDAB) proposed Upper Payment Limit (UPL) plan.
PIPC recently submitted comments to the Oregon Prescription Drug Affordability Board (PDAB) to avoid using studies that rely on discriminatory metrics such as the Quality-Adjusted Life Year (QALY) that have detrimental implications for access to needed care and treatment. The letter also encourages the Oregon PDAB to include patients and people with disabilities throughout its decision-making process.
The Partnership to Improve Patient Care (PIPC) recently submitted comments on the Institute for Clinical and Economic Review's (ICER) assessment of treatments for for Epstein-Barr virus positive post-transplant lymphoproliferative disease.
The Centers for Medicare and Medicaid Services (CMS) recently published final guidance governing its implementation of the Medicare Drug Price Negotiation Program for 2026-2027. The Partnership to Improve Patient Care (PIPC) shares the goal of advancing affordability of health care for all patients and people with disabilities.
38 organizations representing patients and people with disabilities strongly urged the Maryland Prescription Drug Affordability Board (PDAB) to prioritize the perspectives of people whose care may be impacted by your decisions as it works to finalize a Plan of Action for Implementing the Process for Setting Upper Payment Limits
The Centers for Medicare and Medicaid Services (CMS) recently announced the prices for the first 10 drugs targeted by the Medicare Drug Price Negotiation Program. The Partnership to Improve Patient Care (PIPC) shares the goal of advancing affordability of health care for all patients and people with disabilities. It is critical that individuals can both afford and access the treatments prescribed by their physicians.
|
Topics
All
Archives
February 2025
|
